The U.S. Supreme Court made a unanimous decision that a group of anti-abortion doctors lacked legal standing to challenge the FDA's regulation of the abortion pill mifepristone. This ruling ensures that mifepristone will continue to be available under existing conditions nationwide.
Members of the Supreme Court unanimously ruled on Thursday that anti-abortion doctors do not have standing to challenge FDA approval of mifepristone, one of two drugs often used in medication abortions. READ: https://t.co/vyVQS6I9vn https://t.co/Z5YrorCQSJ
Members of the Supreme Court unanimously ruled that anti-abortion doctors do not have standing to challenge FDA approval of mifepristone, one of two drugs often used in medication abortions. READ: https://t.co/vyVQS6I9vn https://t.co/RhLJRKSGez
Members of the Supreme Court unanimously ruled that anti-abortion doctors do not have standing to challenge approval of mifepristone, one of two drugs often used in medication abortions, by the Food and Drug Administration. READ: https://t.co/vyVQS6I9vn https://t.co/U7C9IQYxB2
The Supreme Court ruled unanimously Thursday that anti-abortion doctors did not have standing to challenge the Food and Drug Administration’s regulation of the abortion pill #mifepristone. https://t.co/yBPKrmI8Vv
In a unanimous decision, the Supreme Court ruled a group of anti-abortion doctors did not have the legal basis to challenge access to mifepristone. https://t.co/hU0FKcFO4e
The U.S. Supreme Court has ruled a group of doctors lack legal standing to challenge the FDA's regulation of the abortion pill mifepristone, preserving access to the medication nationwide. @TerryMoran has more. https://t.co/2jMMt2M4CM https://t.co/OBVsmJWLdB
The Supreme Court ruled that a group of anti-abortion doctors does not have any legal basis to challenge access to mifepristone, a drug used in medication abortion. As a result, access to mifepristone will not change. @GeoffRBennett speaks to @johnyangtv for more. https://t.co/n8TMw4iHm9
The U.S. Supreme Court on Thursday ruled a group of doctors lacked legal standing to challenge the @US_FDA's regulation of the abortion pill, mifepristone. The ruling means mifepristone will remain available under preexisting conditions. https://t.co/lgUtyfIK1J https://t.co/LP4ztERKh7